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Poly(I:C) promotes TNFa/TNFR1-dependent
oligodendrocyte death in mixed glial cultures
Andrew J Steelman and Jianrong Li*
Abstract
Background: Activation of glial cells via toll-like receptors (TLRs) and other intracellular pathogen recognition
receptors promotes the release of potentially toxic acute phase reactants such as TNFa and nitric oxide into the
extracellular space. As such, prolonged glial activation, as is thought to occur during a persistent viral infection of
the CNS, may contribute to both neurodegeneration and demyelination. However, the effects of virus-induced glial
activation on oligodendrocytes are not fully understood.
Method: To determine the effects of glial activation on oligodendrocyte viability we treated primary glial cultures
isolated from neonatal rats or mice with the RNA viral mimic poly(I:C) and in some cases other TLR ligands. TLR3
expression was determined by western blot. Cytokine levels were measured by RT-PCR, ELISA, and intracellular
cytokine staining. Oligodendrocyte precursor (preOL) viability was determined by Alamar blue assays and
immunocytochemistry.
Result: Stimulation of mixed glial cultures with poly(I:C) resulted in microglia activation, TNFa production and
preOL toxicity. This toxic effect of poly(I:C) was indirect as it failed to affect preOL viability in pure cultures despite
the fact that preOLs express TLR3. Poly(I:C)-induced loss of preOLs was abolished in TNFa or TNFR1 deficient mixed
glial cultures, suggesting that TNFa/TNFR1 signaling is required for poly(I:C) toxicity. Furthermore, although both
microglia and astrocytes express functional TLR3, only microglia produced TNFa in culture. Consistent with these
findings, other TLR agonists similarly triggered TNFa production and preOL toxicity in mixed glial cultures.
Conclusion: Activation of microglia by poly(I:C) promotes TNFa/TNFR1-dependent oligodendroglial cell death.
These data indicate that during an ongoing viral infection of the CNS, microglial TNFa may be detrimental to
oligodendrocytes.
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Background
The central nervous system (CNS) is considered
immune privileged, but is not without a functional
defense system [1]. Specifically, no organized lymphoid
tissues or professional antigen presenting cells are
thought to exist in the healthy CNS parenchyma. How-
ever, both resident microglia and astrocytes have been
shown to possess immune surveillance properties and
are thought to contribute to the chemoattraction and
stimulation of antigen primed T-cells [2,3]. An innate
ability to distinguish self from non-self is imperative for
the limitation of pathogen spread, the stimulation of
adaptive immune responses and the induction of tissue
repair [4,5]. Toll-like receptors (TLR), nucleotide-oligo-
merization domain (NOD)-like receptors, and intracellu-
lar retinoic acid-inducible gene I (RIG-I)-like receptors
all play an integral role in this process through the up-
regulation of cytokines, chemokines, and costimulatory
molecules following ligation of specific pathogen asso-
ciated molecular patterns [6].
Several intracellular viral recognition receptors are
constitutively expressed in the CNS and can be up-regu-
lated upon stimulation [7]. Included in these receptors
are TLR3 [8], RIG-I [9,10] and melanoma differentia-
tion-associated protein-5 (MDA-5) which have been
shown to be expressed in microglia and astrocytes
[10,11] as well as neurons [8,12-14] and
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oligodendrocytes [15,16]. While the activation of TLR3
in astrocytes by RNA viral mimic polyinosinic:polycy-
tidylic acid (poly(I:C)) causes the release of soluble
molecules with neuroprotective properties [7], over-acti-
vation of TLRs in the absence of immunoregulation may
be detrimental to the surrounding tissue [17-21].
Direct viral infections or aberrant inflammation conse-
quent of previous infection are known to contribute to
both animal and human demyelinating diseases [22]. For
instance, experimental infection of animals with Thei-
ler’s murine encephalomyelitis, mouse hepatitis and
Semliki Forest viruses cause demyelination of the CNS
[22]. Also, multiple human demyelinating diseases can
result from viral infection or vaccination, such as pro-
gressive multifocal leukoencephalopathy, human T-cell
lymphotropic virus type I-associated myelopathy, suba-
cute sclerosing panencephalitis and acute disseminated
encephalomyelitis [22]. Viral infections have also been
implicated in the onset of multiple sclerosis (MS), the
most common demyelinating disease of the CNS [23].
Interestingly, TLR3 expression has been shown to be
increased in both astrocytes and microglia in chronic
MS lesions and is co-localized with its endogenous
ligand stathmin, implicating a role for the activation of
this particular TLR in MS pathogenesis [8].
Previous studies have demonstrated that lipopolysac-
charide (LPS) and subsequent activation of TLR4 is cap-
able of inducing oligodendrocyte death in vivo as well as
in vitro [17] and that this cell death is dependent on
both TNFa production [24] and TNFR1 signaling [25].
The stimulation of mixed glial cultures with LPS pro-
vides a relevant model with which to study certain CNS
white matter pathology brought on by gram-negative
bacteria, which are thought to contribute to periventri-
cular leukomalacia, a major cause of cerebral palsy.
However, the use of LPS in vitro may not accurately
reflect inflammatory responses of glial cells during a
viral infection; particularly since the pattern recognition
receptors that recognize LPS and poly(I:C) are distinct
and unequally distributed in parenchymal cells [15].
Direct viral infection of glial cultures provides a relevant
tool to model CNS viral-induced pathogenesis and/or
tropism. However, infection of CNS-derived cultures
with live virus often makes it difficult to separate virus-
induced cytopathic effect (i.e. cell lysis) from bystander
effects of activated glia.
While poly(I:C) can activate both microglia [26] and
astrocytes [27], the impact of this activation on oligo-
dendrocyte viability has not yet been established. Herein,
we demonstrate that poly(I:C) stimulation of mixed glial
cultures results in a reduction of oligodendrocyte pre-
cursor (preOL) viability in a TNFa- and TNFR1-depen-
dent mechanism. Interestingly, the effects of poly(I:C)
stimulation were very similar to those induced by LPS
stimulation, and suggest that without proper regulation
of glial inflammatory responses, aberrant production of
TNFa within the CNS can be detrimental to developing
oligodendrocytes.
Methods
Mice and rats
Primary cells (mono-, co-, and mixed glial cultures as
well as splenocytes) were isolated from Sprague Dawley
rats (Harland; Houston TX). Mouse cells were obtained
from wildtype B6.129SF2/J, C57BL/6J, and TNFa-/-
(background B6.129SF2/J) and TNFR1-/- (background
C57BL/6J) mice from The Jackson Laboratory (Bar Har-
bor, ME). Animals were housed under constant 12 h
light/dark cycles in covered cages and fed with a stan-
dard rodent diet ad libitum. All experimental proce-
dures were approved by the Institutional Animal Care
and Use Committee and were performed in accordance
with guidelines of the National Institutes of Health.
Isolation of primary cells
Oligodendrocytes, microglia, astrocytes and mixed glial
cultures were isolated from the forebrains of 1 to 2-d-
old Sprague Dawley rats or mice using a differential
detachment procedure [28]. Briefly, after brain dissec-
tion and removal of the meninges the forebrains were
digested with HBSS containing 0.01% trypsin and 10 μg/
ml DNase for 5 min at 37°C. The cells were washed
twice with Dulbecco’s Modified Eagle Media (DMEM)
containing 10% heat-inactivated fetal bovine serum and
1% penicillin-streptomycin. Following filtration through
a sterile 70 μm filter to remove excess debris, the cells
were counted and plated onto poly-d-lysine coated 75
cm2 flasks or directly into 24-well plates for experiments
using mixed glia. For mixed glial culture experiments,
the medium was changed every other day and cells were
treated after 7-8 days in vitro (DIV) in serum-free Basal
Defined Medium (BDM: DMEM containing 0.1% bovine
serum albumin, 50 μg/ml human apo-transferrin, 50 μg/
ml insulin, 30 nM sodium selenite, 10 nM D-biotin, and
10 nM hydrocortisone). For experiments involving
mono and co-cultures, microglia were isolated by shak-
ing the mixed glia-containing flasks for 1 h at 200 rpm.
After removing microglia, the flasks were shaken over-
night to separate preOLs from the astrocyte layer. Single
cell suspensions from rat spleens [29] were used as a
positive control for TLR3 western blot analysis. Briefly,
the external capsule of the spleen was broken and cells
passed through sterile 70 μm nylon mesh twice in
DMEM containing 10% FBS. The cells were pelleted by
centrifugation at 1500 × g for 5 min and the red blood
cells were lysed with ammonium chloride (0.01 M) in
PBS for 3 min at 24°C. The splenocytes were then
washed in PBS.
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Immunocytochemistry
Cells were fixed with 4% paraformaldehyde (PFA) in
PBS (pH 7.4) for 10 min at room temperature, blocked
with 5% goat serum in PBS for 1 h at room temperature
and incubated with the O4 antibody (1:500) overnight at
4°C. After washing with PBS, they were incubated with
fluorescence conjugated goat anti-mouse IgM (Invitro-
gen, Carlsbad, CA) for 1 h. Following washing they were
post-fixed with 4% PFA for 10 min, and blocked and
permeabilized with 5% goat serum in TBS containing
0.1% Triton-X 100 (TBST) for 1 h, and then incubated
with either anti-Iba1 (1:500, rabbit IgG; Wako, Rich-
mond, VA) or anti-GFAP (1:100, rabbit IgG; Invitrogen,
Carlsbad, CA) overnight at 4°C. The cells were incu-
bated with fluorescence conjugated goat anti-rabbit IgG
(Invitrogen, Carlsbad, CA) for 1 h at room temperature,
and counter stained with Hoechst (Invitrogen, Carlsbad,
CA) as described previously [24].
TNFa measurement and intracellular cytokine staining
Rat and mouse TNFa levels were measured from super-
natants by ELISA kits according to the manufacturer’s
instructions (eBioscience; San Diego, CA.). Intracellular
cytokine staining of TNFa was performed as described
previously [25]. Briefly, mixed glial cultures were washed
twice with media then treated with media, PBS, poly(I:C)
(50 μg/ml; Sigma, St. Louis, MO) or LPS (1.0 μg/ml;
Sigma, St. Louis, MO) for 8 or 24 h at 37°C. During the
last 5 h of stimulation, protein secretion was inhibited
using Brefeldin-A (eBioscience; San Diego, CA.) diluted
1:1000 in BDM alone or in BDM containing poly(I:C) or
LPS. The cells were then fixed and immunostained as
described above.
RT-PCR
Transcriptional expression of Iba-1, GFAP, TLR3,
TNFa, IL-1b, and IL-6 in microglia and astrocyte mono-
cultures upon stimulation with poly(I:C) was examined
as described previously [25]. Briefly, cells were plated
onto poly-D-lysine coated 6-well plates at a density of
1.0 × 106 cells per well in DMEM containing 10% fetal
bovine serum. After 24 h, cells were washed twice with
BDM medium, and then treated with poly(I:C) (50 μg/
ml) or vehicle control (PBS) for 0-24 h. RNeasy kits
were used to extract RNA according to the manufac-
turers’ instructions (Qiagen, Valencia, CA). Residual
DNA was digested by incubating RNA samples with
DNase I for 15 min at room temperature followed by
DNase inactivation at 65°C for 10 min according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA).
The samples were reverse transcribed to cDNA using
the reverse transcription system kit (Promega, Madison,
WI) as described previously [25]. The purity of the
mono-cultures was determined using specific primers
for GFAP (astrocyte marker) and Iba-1 (microglia mar-
ker). Primers specific for b-actin were used as a loading
control. All products were amplified by PCR using 100
ng of cDNA and the following primers: TLR3, forward-
TGCGATTGGCAAGTTATTCG, reverse-GCGGAG
GCTGTTGTAGGAAA; TNF, forward-GCCCACGTCG-
TAGCAAAC, reverse-GCAGCCTTGTCCCTTGAA; IL-
1b, forward-TGACCCATGTGAGCTGAAAG, reverse-
AGGGATTTTGTCGTTGCTTG; IL-6, forward-CAG-
GAACGAAAGTCAACTCCA, reverse-ATCAGTCC-
CAAGAAGGCAACT; CCL2, forward-CCAGCCCA
GAAACCAGCCAACTC, reverse-GCATCTGGCTGA-
GACAGCACGT; CCL5, forward-AGCAGCAAGTGC
TCCAACCTTG, reverse-GCACACCTCCCAGGCCA-
TAGGA; GFAP, forward-CAGCTT CGAGCCAAG-
GAG, reverse-TGTCCCTCTCCACCTCCA; Iba1,
forward-CTTTTGGACTGCTGAAAGCC, reverse-GTT
TCTCCAGCATTCGCTTC; and b-actin, forward-
AGACTTCGAGCAGGAGATGG, reverse-CCATCAT-
GAAGTGTGACGTTG. Products were electrophorezed
on 2% agarose gels and visualized under UV light using
a Bio-Rad Chemidoc XRS gel documentation system
and Quantity-one software. Quantitative PCR was used
to determine fold increase in CCL2 and CCL5 relative
to b-actin using the formula 2-ΔΔCt as described pre-
viously [30].
Cell Viability Assays
Cell viability following TLR agonist treatment was
assessed using both immunocytochemical and biochem-
ical techniques. Lactate dehydrogenase (LDH) activity
was assessed from culture supernatants according to the
manufacturer’s instructions (Roche Applied Science;
Indianapolis, IN). The effects of treatment on preOL
viability in mixed glial cultures were determined 48 h
after treatment with Pam3CSK4 (1.0 μg/ml; InvivoGen,
San Diego, CA), poly(I:C) (50 μg/ml and 5 μg/ml), LPS
(1.0 and 0.1 μg/ml) or R848 (5.0 μg/ml; InvivoGen, San
Diego, CA) by counting the number of normal appear-
ing nucleated O4+ cells per 200× magnification from 5
random fields per culture well. O4- cells most likely
representing microglia and astrocytes were excluded
from the analysis. Pictures were taken using an Olympus
DP70 digital camera mounted on an Olympus IX71
microscope. All treatments were conducted in at least
triplicate, corresponding to between 750-1000 cells
counted per treatment condition per experiment.
Experiments were replicated at least three times. For
each experiment the average number of O4+ cells in the
control group was used to obtain percent reduction, and
the percent reduction averaged across experiments. The
effects of various treatments in pure preOL cultures
were assessed by Alamar blue assay as described pre-
viously [24].
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Western blot
Cell lysates from microglia, astrocyte and oligodendro-
cyte monocultures as well as splenocytes were used to
determine the presence of TLR3 protein. Briefly, cells
were lysed on ice in standard lysis buffer (10 mM
Na2P2O7, 10 mM NaF, 100 mM Na3VO4 100 mM
PMSF proteinase inhibitor cocktail; Roche) and then
sonicated. Cell debris was pelleted by centrifugation at
16000 × g for 15 min at 4°C. Total proteins (20 μg)
were separated by SDS-polyacrylamide gel electrophor-
esis followed by transferring to PVDF membranes. After
blocking with TBS-T (50 mM Tris-HCl, pH 7.4, 150
mM NaCl, 0.1% Tween-20) containing 5% non-fat milk
for 1 h at RT the membranes were incubated with anti-
TLR3 (1: 200, Rabbit IgG, Santa Cruz Biotech, Santa
Cruz, CA.) overnight at 4°C or b-actin (1:10,000, Mouse
IgG, Sigma, St. Louis, MO) diluted in TBS-T containing
5% non-fat milk. The membranes were washed 3-5
times with TBS-T, and then incubated with horseradish
peroxidase conjugated secondary antibody for 1 h. Fol-
lowing additional washes bands were detected by
chemiluminescence using the SuperSignal detection kit
(Thermo Scientific, Rockford, IL).
Statistics
All data are expressed as means ± SEM. Data were
analyzed using two-tailed student’s t-tests for compari-
sons between two groups or multiple level analysis of
variance (ANOVA) followed by Bonferroni’s post-hoc
test where appropriate to distinguish differences
between multiple groups. All statistics were calculated
using GraphPad Prism 4 (GraphPad Software, San
Diego, CA). Differences were considered significant
when p < 0.05.
Results
Poly(I:C) activates microglia and induces pre-
oligodendrocyte cell death in mixed glial cultures
Treatment of mixed glial cultures with poly(I:C) caused
robust microglial activation as indicated by marked
changes in morphology (Figure 1A), TNFa secretion
(Figure 1B) and increased cell death as determined by
Figure 1 Stimulation of mixed glial cultures with poly(I:C) causes microglia activation and preOL cell death. Rat mixed glial cultures
were stimulated with vehicle (sterile PBS; 5 μl/ml) or poly(I:C) (50 μg/ml) in BDM for 48 h. A: Immunocytochemical staining showing changes in
microglia morphology (Iba-1; green) with process extensions closely associated with O4+ preOLs (red) in poly(I:C) treated cultures (arrows). Scale
bar, 50 μm. B, C: Poly(I:C) stimulated cultures had elevated TNFa (B) and LDH (C) in culture supernatants as determined by ELISA and LDH
assays respectively. D. O4+ cell viability was decreased following in poly(I:C) treatment. Results in A are representative of 3 independent
experiments. Results from B-D are combined means ± SEM of 4-5 independent experiments.
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LDH release 48 h after the treatment (Figure 1C). Pro-
cesses of poly(I:C)-activated microglia were frequently
found to be in close proximity to preOLs, suggesting an
increase in their surveillance properties (Figure 1A,
arrow). Immunocytochemical analysis revealed an
approximate 28% loss of preOLs in the poly(I:C) stimu-
lated cultures when compared to control cultures (Fig-
ure 1D). Furthermore, poly(I:C) reduced preOL viability
in a dose-dependent manner that appeared to correlate
with TNF production (Figure 2A-D). These data indicate
that poly(I:C) stimulation in mixed glial cultures is toxic
to preOLs.
Poly(I:C) is not directly toxic to pre-oligodendrocytes
As oligodendrocytes, astrocytes and microglia reportedly
express TLR3 [7,15], a prominent receptor for poly(I:C),
it was possible that preOLs in mixed glial cultures were
dying in a cell autonomous fashion in response to poly(I:
C). Consistent with previous reports, western blot
analysis revealed that all glial cells expressed TLR3 in
culture (Figure 3A). To examine the direct effects of poly
(I:C) on preOLs, purified preOL cultures were stimulated
with increasing concentrations of poly(I:C) and cell viabi-
lity was determined. In contrast to poly(I:C)-induced
preOL death in mixed glial cultures, we found that poly
(I:C) was not toxic to pure preOLs (Figure 3B-C).
Instead, poly(I:C) treatment appeared to result in
increased viability, but this effect was not statistically
significant.
TNFa and its cognate receptor R1 are responsible for pre-
oligodendrocyte cell death following poly(I:C) stimulation
in mixed glia cultures
To test whether the detrimental effects of poly(I:C) were
attributable to TNFa production, we prepared mixed
glial cultures from TNFa-/-, TNFR1-/- and their corre-
sponding wildtype (WT) mice. As we previously found
that both TNFa production and TNFR1 signaling are
Figure 2 Poly(I:C) mediated reduction in preOL viability is dose-dependent. Rat mixed glial cultures were stimulated with vehicle (sterile
PBS; 5 μl/ml), poly(I:C) (5 and 50 μg/ml), or LPS (positive control; 0.1 and 1.0 μg/ml) for 48 h. A, B: Poly(I:C) dose-dependently increased TNFa
levels as measured by ELISA (A) and reduced preOL viability at 50 μg/ml but not 5 μg/ml (B). C, D: Stimulation of mixed glia with 0.1 and 1.0
μg/ml of LPS induced similar levels of TNFa production (C) and loss of preOL viability (D). Results are combined means ± SEM from 3
independent experiments. *, p < 0.05, **, p < 0.01.
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required for LPS-induced preOL cytotoxicity in mixed
glial cultures, we used LPS as a positive control [24,25].
Similar to LPS, poly(I:C) induced significant TNFa pro-
duction in B6129 (WT), C57BL/6 (WT) and TNFR1-/- ,
but not in TNFa-/- mixed glial cultures (Figure 4A&4D).
TNFa production from poly(I:C) stimulated cultures
was generally lower than those stimulated with LPS, an
effect that was significant in B6129 and TNFR1-/- cul-
tures (Figure 4A&4D).
To determine if preOL viability decreased upon poly
(I:C) stimulation in various cultures we counted the
number of preOLs under each condition. Consistent
with the above data, stimulation of WT cultures with
poly(I:C) or LPS resulted in significant loss of O4+
cells compared to vehicle control treated cultures (Fig-
ure 4B&4E). In contrast, this cytotoxic effect was abol-
ished in TNFa deficient mixed glial cultures (Figure
4C). Deletion of the TNFa receptor tnfr1 also abro-
gated the poly(I:C)-triggered TNF-mediated toxicity to
preOLs (Figure 4F) despite a comparable level of
TNFa production in WT and TNFR1-/- cultures (Fig-
ure 4D). These results demonstrate that TNFa is
required for oligodendroglial cell death in mixed
cultures challenged with poly(I:C) or LPS and that the
signal needed to induce cell death is dependent on
TNFR1.
Microglia are the sole source of TNFa secretion after poly
(I:C) stimulation in culture
Both microglia and astrocytes are capable of cytokine
and chemokine secretion following recognition of var-
ious pathogen associated molecular patterns including
poly(I:C). To determine the cellular source of TNFa
secretion in our cultures, purified microglia, astrocytes
or oligodendrocytes were treated with PBS or poly(I:C)
for 24 h and TNFa levels were determined by ELISA.
We found that microglia, but neither astrocytes nor oli-
godendrocytes, produced TNFa following poly(I:C) sti-
mulation (Figure 5A). To confirm this finding, we then
conducted RT-PCR analysis on RNA isolated from
microglia and astrocyte monocultures stimulated with
or without poly(I:C) for 24 h. Both microglia and astro-
cytes expressed TLR3. TNFa and IL-1b transcripts were
induced by poly(I:C) in microglia, but undetectable in
astrocytes. Moreover, transcription of IL-6 was evident
in stimulated microglia and in poly(I:C) stimulated
Figure 3 Poly(I:C) stimulation is not directly toxic to preOLs. A: Western blot analysis of TLR3 expression in astrocyte (AST), oligodendrocytes
(OL), and microglia (MG). Splenocytes were used as a positive control. B: Poly(I:C) did not cause cell death in pure preOL cultures. PreOLs were
treated with increasing concentrations of poly(I:C) for 48 h and cell viability measured by Alamar blue. Results are combined means ± SEM of 4
independent experiments; ns, not significant. C: Representative phase-contrast images of preOLs treated as above. Scale bar, 100 μm.
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astrocytes (Figure 5B). The expression of the macro-
phage/microglia marker Iba-1 and astrocyte marker
GFAP from the same samples indicated that there was
virtually no microglia contamination of astrocyte cul-
tures, but some astrocyte contamination in microglia
cultures (Figure 5B). Additionally, microglia but not
astrocytes responded to poly(I:C) by producing TNFa in
a dose- and time-dependent fashion (Figure 5C). These
results strongly indicate that microglia are the producers
of TNFa in mixed glial cultures.
To further determine whether microglia were indeed
the TNFa producers and to test whether microglia-
derived factors were capable of inducing astroglial
TNFa, we performed intracellular cytokine staining for
TNFa in mixed cultures treated with poly(I:C). We
found that TNFa+ cells with microglia morphology were
abundant upon stimulation with poly(I:C) or LPS, but
were absent in vehicle control treated mixed glial cul-
tures (Figure 5D). Immunostaining of poly(I:C)-stimu-
lated cultures with an isotype control antibody did not
Figure 4 Both TNFa production and TNFR1 are required for poly(I:C)-induced preOL death in mixed glial cultures. Mixed glial cultures
derived from WT, TNF-/- or TNFR1-/- were stimulated with vehicle (sterile PBS; 5 μl/ml), poly(I:C) (50 μg/ml), or LPS (1.0 μg/ml) for 48 h. A, D:
TNFa production as determined by ELISA. Results are means ± SEM of 3 independent experiments. B-C; E-F: PreOL viability as determined by
O4+ cell counting. Both LPS and poly(I:C) caused preOL toxicity in cultures derived from WT B6129 (B) and WT C57BL/6 (E) mice, but had no
effect in cultures derived from TNF-/- (C) or TNFR1-/- (F) mice. Results are means ± SEM of 3 independent experiments for each mouse strain. *, p
< 0.05, **, p < 0.01, ***, p < 0.001.
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reveal any non-specific signal (not shown). Importantly,
dual staining for TNFa and either GFAP or Iba-1
demonstrated that astrocytes did not produce TNFa fol-
lowing stimulation with LPS or poly(I:C) as TNFa+ cells
never localized to GFAP+ cells (Figure 5D). Instead,
TNFa immunoreactivity was confined to Iba-1+ cells,
indicating microglia as being the sole source of TNFa
under these conditions (Figure 5E).
Our observation that astrocytes express TLR3, yet
did not produce TNFa following poly(I:C) stimulation
raised the possibility that poly(I:C) was incapable of
activating astrocytes under our experimental
Figure 5 Microglia produce TNFa following poly(I:C) stimulation. A: Microglia (MG), astrocytes (AST) or oligodendrocytes (OL) were treated
with or without poly(I:C) (PIC; 50 μg/ml) for 24 h and TNFa levels were determined by ELISA. Results are means ± SEM of 3 independent
experiments. B: Expression of TLR3 (top), TNFa, IL-1b, IL-6, Iba-1 and GFAP (bottom) was determined by RT-PCR from monocultures treated with
PBS or poly(I:C) for 24 h. Results are from 2 independent experiments and are representative of 3 independent experiments for each product. C:
Kinetic analysis of TNFa production following stimulation with varying doses of poly(I:C) in microglia (left) and astrocyte (right) monocultures.
Results are combined means ± SEM of triplicate wells and are representative of 3 independent experiments. D, E: Intracellular cytokine staining
of mixed glial cultures treated with vehicle (sterile PBS; 5 μl/ml), poly(I:C) or LPS for 8 h. TNFa immunoreactivity did not localize to GFAP+
astrocytes (D), but instead to Iba-1+ microglia (E). Results are representative of 3 independent experiments. F: Expression of TNFa, CCL2 and
CCL5 was determined by RT-PCR from astrocytes treated with vehicle (sterile PBS; 5 μl/ml) or poly(I:C) (50 μg/ml) for 3-6 h (left) or increasing
concentrations (right) of poly(I:C) for 6 h. Results are representative of 2 independent experiments. G-J: Both CCL2 (G, I) and CCL5 (H, J)
expression were dose- and time-dependently increased upon poly(I:C) stimulation. Results are means ± SEM from duplicate (CCL2) or triplicate
(CCL5) samples and are representative of 3 independent experiments. *, p < 0.05, **, p < 0.01, ***, p < 0.001.
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paradigms. To test whether exogenous poly(I:C) was
sufficient to elicit a response from astrocytes, we next
determined the expression of chemokines CCL2 and
CCL5, which have been previously reported to be sub-
stantially induced in astrocytes following extracellular
poly(I:C) stimulation [11,27]. Again, while stimulation
of astrocytes with poly(I:C) resulted in negligible
TNFa transcription we observed marked up-regulation
of both CCL2 and CCL5 in a time- and dose-depen-
dent fashion (Figure 5F), which was further confirmed
by qRT-PCR analyses (Figure 5G-J). These results indi-
cate that astrocytes indeed respond to poly(I:C) and
produce chemokines while at the same time fail to
transcribe TNFa.
Stimulation of mixed glial cultures with other TLR ligands
causes toxicity to preOLs
Our above data demonstrate that stimulation of mixed
glial cultures with poly(I:C), a mimic of double-stranded
RNA viral infection, is toxic to preOLs. Similar to what
we have shown previously after LPS challenge [24,25],
the toxicity triggered by poly(I:C) is also dependent on
the TNFa/TNFR1 pathway. Because ligation of other
TLRs on microglia can also induce TNFa production
[31], we questioned whether stimulation of mixed glia
with additional TLR ligands could also result in reduced
preOL viability. Indeed, stimulation of mixed cultures
with TLR1/2 agonist Pam3CSK4 or TLR7/8 agonist
R848 triggered TNFa production (Table 1) with LPS sti-
mulation causing significantly more TNFa production
than any other TLR agonists tested. All tested TLR ago-
nists resulted in a significant reduction in O4+ cell viabi-
lity that was most pronounced following treatment with
LPS and R848 (Figure 6). Together, these data support a
role for aberrant TNFa production in mediating preOL
death.
Discussion
In the current study we demonstrate that stimulation of
mixed glial cultures with the viral mimic poly(I:C)
causes preOL death in a non-cell autonomous fashion
and through a TNFa/TNFR1-dependent mechanism.
TNFa was derived exclusively from activated microglia
as astrocytes neither secreted TNFa nor expressed intra-
cellular TNFa following poly(I:C) stimulation. This was
surprising as astrocytes clearly express TLR3
[7,15,32-34], RIG-I [10,35] and MDA-5 [11] and have
been shown to produce TNFa in vivo [36-39]. As these
receptors are predominantly intracellular, a plausible
explanation for these results could be the exogenous
manner of the treatment. However, the fact that astro-
cytes up-regulated chemokines CCL2 and CCL5, but
failed to induce TNFa indicates that exogenous poly(I:
C) is capable of activating astrocytes thereby excluding
the above possibility. In line with this finding, several
recent studies have demonstrated that astrocytes stimu-
lated with exogenous poly(I:C) dramatically increase
cytokines IL-6, IFN-b, IL-8 and chemokine CCL2 and
CCL5, but produce only negligible amounts of TNFa
[11,27]. Moreover, flow cytometric analysis by Zhou et
al. convincingly demonstrates that while astrocytes
express CCL2 following Pam3CSK4, poly(I:C) or LPS
stimulation or LCMV infection, they do not express
TNFa [40]. Together, these results strongly indicate
either that, microglia are far superior at TNFa produc-
tion when compared to astrocytes in vitro or that TNFa
production in astrocyte cultures is attributable to resi-
dual microglia.
To date several studies have demonstrated reduced
preOL viability following LPS stimulation of microglia/
preOL co-cultures [28] or mixed glial cultures contain-
ing astrocytes [17,24,25,41]. Mechanistically, it has been
shown that NO-derived peroxynitrite is required for
mediating toxicity to preOLs in microglia/preOL co-cul-
tures [28] and may indeed participate in the initial
reduction of preOL viability (after 24 h) in mixed cul-
tures [41]. However, 48 h of LPS stimulation in mixed
glial cultures results in a loss of preOL viability that is
attributable to TNFa [24,25,41]. As with other studies,
the current set of experiments implicates aberrant
TNFa production in the demise of oligodendrocytes
[17,24,41,42], but the exact role of TNFa in the patho-
genesis of demyelination in vivo are not yet fully under-
stood. For instance, stimulation of mixed glial cultures
with LPS results in TNFa production, which is toxic to
oligodendrocytes in vitro [17,24,43]. TNFa has also been
shown to be directly toxic to oligodendrocytes in vitro
[44]. Moreover, in transgenic mice in which astrocytes
express transmembrane TNFa demonstrate oligoden-
drocyte death and develop demyelination [42]. In agree-
ment with this observation, we have shown that both
astrocytes and oligodendroglial TNFR1 are required for
TNFa-mediated oligodendrocyte toxicity in vitro [25].
Furthermore, direct cell-cell contact between astrocytes
Table 1 TNFa production in mixed glial cultures
stimulated with TLR agonists
Stimulus TLR ligand TNFa (pg/ml) Significance
Control N/A 36.14 ± 3.112
Pam3CSK4 TLR1/2 1865 ± 353.5 p < 0.01
poly(I:C) TLR3 1420 ± 73.39 p < 0.05
LPS TLR4 4645 ± 214.4* p < 0.001
R848 TLR7/8 1972 ± 361.1 p < 0.001
Mixed glia were stimulated for 48 h with various TLR ligands and TNFa
measured from culture supernatants by ELISA. Results are combined means ±
SEM from 4 independent experiments. *LPS stimulation resulted in
significantly higher TNFa production compared to all other TLR ligands (p ’s <
0.001).
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and oligodendrocytes mediates the TNFa toxicity.
Therefore, accumulating data suggest that microglia as
well as astrocytes are required for TLR agonist induced
preOL toxicity.
It is important to note that the mixed glial cultures
used in this study did not contain neurons. As func-
tional neurons constitutively express several immunore-
gulatory molecules such as CD200 [45] and CX3CL1
[46] that are capable of modulating microglia activation
and cytokine production, it is possible that stimulation
of mixed neuronal cultures with poly(I:C) might mitigate
the toxic effect on preOL. Thus, future experiments are
needed to examine the effect of neurons on microglia
inflammatory responses and preOL viability. However,
several lines of evidence indicate that TLR ligation can
contribute to tissue destruction within the CNS. For
instance, stereotaxic injection of zymosan, a TLR2
ligand, into either the corpus callosum [20] or spinal
cord [21] causes microglia activation and demyelination.
Likewise, stereotaxic injection of LPS into the spinal
cord induces demyelination [19]. Moreover, poly(I:C)
injection into the substantia nigra pars compacta was
shown to trigger microglia activation and neurodegen-
eration at high doses or susceptibility to neurodegenera-
tion at subtoxic levels [18]. While these studies suggest
that acute microglia activation subsequent to TLR liga-
tion is detrimental to the surrounding tissues, certainly
not all microglial responses result in neurodegeneration.
Some can in fact promote tissue repair [4]. For instance,
intravitreal injection of zymosan is associated with an
increase in TGFb1 and IL-1b production and induces
myelination of retina [47]; and LPS treatment concur-
rent to detergent ethidium bromide-induced demyelina-
tion promotes repair, possibly through the recruitment
of oligodendrocyte progenitors to the lesion [48].
Likewise, not all studies have assigned a detrimental
role to TNFa in the CNS. For example, while injection
of recombinant TNFa into the optic nerve resulted in
demyelination [49], repeated intracerebral injection of
TNFa resulted in hemorrhage, reactive gliosis and infil-
tration of mononuclear and polymorphonuclear cells
but appeared to have no cytolytic effects [50]. Moreover,
in the cuprizone model of toxic demyelination, which is
characterized by extensive reactive gliosis, TNFa-/- mice
exhibit delayed demyelination but also impaired remyeli-
nation [36]. In addition, it has recently been shown that
the resolution of pathology following virus-induced
encephalitis requires TNFa for repair in the striatum
and the hippocampus through TNFR1 and TNFR2
respectively [51]. On the other hand, Theiler’s murine
encephalomyelitis virus infection of TNFR1-/- were
found to exhibit up to 80% fewer seizures during virus-
induced encephalitis when compared to control mice
[52].
Figure 6 Stimulation of mixed glia with TLR2 and TLR7 agonists increases TNFa and promotes preOL cytotoxicity. Rat mixed glial
cultures were treated with vehicle (sterile PBS; 5 μl/ml), TLR1/2 agonist Pam3CSK4 (1.0 μg/ml), TLR3 agonist poly(I:C) (50 μg/ml), TLR4 agonist
LPS (1.0 μg/ml) or TLR7/8 agonist R848 (5.0 μg/ml) for 48 h. PreOL viability was determined by counting O4+ cells. Scale bar, 50 μm. Results are
combined means ± SEM from 4 independent experiments. *, p < 0.05, **, p < 0.01, ***, p < 0.001.
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Ambiguous effects of TNFa have also been demon-
strated in multiple sclerosis. Elevated TNFa levels in the
cerebral spinal fluid of MS patients precede exacerbation
and correlate with disease progression [39]. TNFa
immunoreactivity has been localized to astrocytes on
the lesion edge but not in the lesion center of MS
patients [37]. Furthermore, increased expression of
TNFR1 and TNFR2 in oligodendrocytes at the edge of
chronic active lesions was reported [53,54]. While these
findings suggest an involvement for TNFa in the patho-
genesis of MS, treatment with monoclonal neutralizing
anti-TNFa antibodies as well as neutralizing soluble
receptors has, paradoxically, resulted in MS disease
exacerbation [55,56]. Even more alarming, anti-TNFa
therapy in rheumatoid arthritis patients has been asso-
ciated with the onset of monophasic demyelination
including optic neuritis that subsided after treatment
withdrawal [57-60] and with the onset of MS [57,61]. As
the capacity for TNFa therapy to neutralize CNS TNFa
was not directly examined, these data may imply that
peripheral TNFa is somehow required for maintaining
demyelinating disease quiescence. Although the underly-
ing mechanism remains unknown the recent finding
that increased susceptibility to MS is associated with a
single nucleotide polymorphism within the sixth intron
of the tnfr1 gene calls upon further investigation as to
the role the TNFa/TNFR1 pathway in this disease
[62,63].
Conclusion
Toll-like receptor expression is not equally represented
across different populations of resident CNS cells. Since
TLR3, a recognition receptor for double-stranded RNA
viruses, is present in all glia, the current study tested the
hypothesis that stimulation of mixed glia with the TLR3
ligand poly(I:C) would exhibit different outcomes than
those following LPS stimulation. Utilizing poly(I:C) to
model the bystander effects of glial activation on preOL
viability following RNA viral infection, we found that
over-activation of glia, specifically microglia, reduced
preOL viability in mixed glial cultures. Mechanistically,
this toxicity was dependent on TNFa/TNFR1 signaling.
Extending on these findings we observed that activation
of TLR1/2 and TLR7/8 had similar effects on preOLs.
Thus, our data indicate that uncontrolled production of
TNFa in the CNS upon viral infection may consequen-
tially contribute to oligodendrocyte death and
demyelination.
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